Inventor · disambiguated record
Mark Allen Hadd
Also filed as: HADD MARK A · HADD MARK ALLEN
7 granted patents·4 pending applications·41 citations·filing 1998–2025
84Inventor score
Top patents by PatentIndex Score
11 records- 0197US11091435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2020·Granted Aug 17, 2021·11 cites·15 claims
- 0297US10676435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2019·Granted Jun 9, 2020·12 cites·25 claims
- 0396US11884626B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2021·Granted Jan 30, 2024·3 cites·16 claims
- 0493US10301262B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2016·Granted May 28, 2019·11 cites·50 claims
- 0590US12378198B2Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2023·Granted Aug 5, 2025·0 cites·40 claims
- 0689US2025346560A1Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disordersARENA PHARM INC·Filed 2025·Application pending·0 cites
- 0773US8952197B2Processes for the preparation of 5-HT2C receptor agonistsDEMATTEI JOHN A·Filed 2010·Granted Feb 10, 2015·3 cites·44 claims
- 0867US2025066383A1Pde 7 modulator compoundsOMEROS CORP·Filed 2024·Application pending·0 cites
- 0950US2015210625A1Processes for the preparation of 5-ht2c receptor agonistsDEMATTEI JOHN A·Filed 2014·Application pending·0 cites
- 1044US2004266848A1Preparation of N2-alkylated 1,2,3-triazolesFiled 2004·Application pending·0 cites
- 1127US5973153AProcess for the preparation of halo-4-phenoxyquinolinesFiled 1998·Granted Oct 26, 1999·1 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Mark Allen Hadd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →